Leuprolide
Back to searchMolecule Structure
Scientific Name
Leuprolide
Description of the Drug
Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00007
http://www.drugbank.ca/drugs/DB00007
Brand Name(s)
Not Available
Company Owner(s)
Tolmar Therapeutics Inc, Sandoz Inc, Ortho Mcneil Janssen Pharmaceutical Inc, Invagen Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Vgyaan Pharmaceuticals Llc, Genzyme Corporation, Accord Biopharma Inc, Eugia Pharma Specialities Ltd, Abbvie Endocrine Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | AGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4585 | |||
Human Metabolome Database | HMDB0041916 | |||
DrugBank | DB00007 | |||
PubChem: Thomson Pharma | 14841815 | 14939439 | 14939438 | 14890460 |
PubChem | 657181 | |||
Nikkaji | J34.477J | |||
BindingDB | 50369395 | |||
EPA CompTox Dashboard | DTXSID50872411 | |||
DrugCentral | 1559 | |||
ChemicalBook | CB8398455 | |||
Guide to Pharmacology | 1175 | |||
rxnorm | LEUPROLIDE ACETATE | LUPRON | ELIGARD | LEUPROLIDE |
ChEBI | 6427 |